Pacific Non Current Assets Total from 2010 to 2024
PACB Stock | USD 1.40 1.44 50.70% |
Non Current Assets Total | First Reported 2009-12-31 | Previous Quarter 1 B | Current Value 1 B | Quarterly Volatility 347.3 M |
Check Pacific Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacific main balance sheet or income statement drivers, such as Depreciation And Amortization of 34.3 M, Interest Expense of 15.1 M or Total Revenue of 210.5 M, as well as many exotic indicators such as Price To Sales Ratio of 11.79, Dividend Yield of 0.0 or PTB Ratio of 4.3. Pacific financial statements analysis is a perfect complement when working with Pacific Biosciences Valuation or Volatility modules.
Pacific | Non Current Assets Total |
Latest Pacific Biosciences' Non Current Assets Total Growth Pattern
Below is the plot of the Non Current Assets Total of Pacific Biosciences of over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Pacific Biosciences' Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pacific Biosciences' overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total | 10 Years Trend |
|
Non Current Assets Total |
Timeline |
Pacific Non Current Assets Total Regression Statistics
Arithmetic Mean | 278,948,020 | |
Geometric Mean | 59,104,409 | |
Coefficient Of Variation | 154.77 | |
Mean Deviation | 367,422,962 | |
Median | 38,616,000 | |
Standard Deviation | 431,729,364 | |
Sample Variance | 186390.2T | |
Range | 1B | |
R-Value | 0.80 | |
Mean Square Error | 73021.9T | |
R-Squared | 0.64 | |
Significance | 0.0004 | |
Slope | 77,001,368 | |
Total Sum of Squares | 2609463.4T |
Pacific Non Current Assets Total History
About Pacific Biosciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Pacific Biosciences income statement, its balance sheet, and the statement of cash flows. Pacific Biosciences investors use historical funamental indicators, such as Pacific Biosciences's Non Current Assets Total, to determine how well the company is positioned to perform in the future. Although Pacific Biosciences investors may use each financial statement separately, they are all related. The changes in Pacific Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Pacific Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Pacific Biosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Pacific Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Non Current Assets Total | 1 B | 1.1 B |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pacific Biosciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of Pacific Biosciences Correlation against competitors. Note that the Pacific Biosciences information on this page should be used as a complementary analysis to other Pacific Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Pacific Stock analysis
When running Pacific Biosciences' price analysis, check to measure Pacific Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacific Biosciences is operating at the current time. Most of Pacific Biosciences' value examination focuses on studying past and present price action to predict the probability of Pacific Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacific Biosciences' price. Additionally, you may evaluate how the addition of Pacific Biosciences to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Pacific Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.21) | Revenue Per Share 0.791 | Quarterly Revenue Growth 1.133 | Return On Assets (0.11) | Return On Equity (0.49) |
The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.